Here is some news of note for the week:
> Halix, a CDMO in the Netherlands, says it completed a five-level production facility for making viral vaccines and viral vectors as well as protein manufacturing at its site in Leiden. Release
> The FDA issued a statement to try to ease consumer concerns over the risks of contaminated sartan drugs. Statement
> The Novo Nordisk Foundation has awarded $27 million in grants to help the improve pharmaceutical processes to be easier on the environment. Release
> CDMO Sterling Pharma Solutions has started large-scale production of silica particles. Release
> Biocon says its insulin facility in Malaysia has been approved by the EU. Release
> Orano Med says it is investing €15 million in facilities in France and the U.S. to develop treatments using radioactive properties. Story